Diagnosis and Differential Diagnosis of Neurological Adverse Events during Immune Checkpoint Inhibitor Therapy

Table 2

Results of radiological and electrophysiological measurements.

		N-irAEs group	DD group
Brain MRI	Cerebral metastases	2/10 (20%)	5/10 (50%)
	Ischemia/ICB	0/10 (0%)	4/10 (40%)
Spinal MRI	Inflammatory changes	3/9 (33%)	0/2 (0%)
	Metastases	1/9 (11%)	2/2 (100%)
Ephys	Polyneuropathy	13/16 (81%)	3/6 (50%)

Numbers indicate positive patients/all patients examined. DD: differential diagnosis; ICB: intracerebral bleeding; Ephys: electrophysiological studies; MRI: magnetic resonance imaging; N-irAEs: neurological adverse events.